Mackenzie Financial’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $495K | Buy |
28,932
+8,751
| +43% | +$150K | ﹤0.01% | 1231 |
|
|
2025
Q1 | $1.29M | Sell |
20,181
-3,081
| -13% | -$197K | ﹤0.01% | 909 |
|
|
2024
Q4 | $2.83M | Sell |
23,262
-9,238
| -28% | -$1.12M | ﹤0.01% | 679 |
|
|
2024
Q3 | $4.06M | Sell |
32,500
-28,761
| -47% | -$3.59M | 0.01% | 583 |
|
|
2024
Q2 | $9.68M | Buy |
61,261
+24,836
| +68% | +$3.92M | 0.01% | 435 |
|
|
2024
Q1 | $4.72M | Buy |
36,425
+26,216
| +257% | +$3.39M | 0.01% | 564 |
|
|
2023
Q4 | $984K | Sell |
10,209
-10,308
| -50% | -$994K | ﹤0.01% | 870 |
|
|
2023
Q3 | $2.47M | Sell |
20,517
-12,330
| -38% | -$1.49M | ﹤0.01% | 667 |
|
|
2023
Q2 | $3.73M | Sell |
32,847
-7,935
| -19% | -$901K | 0.01% | 614 |
|
|
2023
Q1 | $5.62M | Sell |
40,782
-4,195
| -9% | -$578K | 0.01% | 526 |
|
|
2022
Q4 | $5.83M | Buy |
44,977
+3,831
| +9% | +$496K | 0.01% | 497 |
|
|
2022
Q3 | $4.55M | Buy |
41,146
+37,393
| +996% | +$4.13M | 0.01% | 545 |
|
|
2022
Q2 | $281K | Buy |
+3,753
| New | +$281K | ﹤0.01% | 1122 |
|
|
2021
Q1 | – | Sell |
-6,755
| Closed | -$1.15M | – | 1192 |
|
|
2020
Q4 | $1.15M | Sell |
6,755
-2,996
| -31% | -$511K | ﹤0.01% | 695 |
|
|
2020
Q3 | $1.37M | Sell |
9,751
-5,018
| -34% | -$705K | ﹤0.01% | 618 |
|
|
2020
Q2 | $2.37M | Buy |
+14,769
| New | +$2.37M | 0.01% | 518 |
|
|
2019
Q2 | – | Sell |
-2,412
| Closed | -$287K | – | 1232 |
|
|
2019
Q1 | $287K | Sell |
2,412
-1,703
| -41% | -$203K | ﹤0.01% | 1113 |
|
|
2018
Q4 | $449K | Buy |
4,115
+560
| +16% | +$61.1K | ﹤0.01% | 957 |
|
|
2018
Q3 | $574K | Buy |
+3,555
| New | +$574K | ﹤0.01% | 851 |
|